Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

7.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.4K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.8K
Patch Clamp01:18

Patch Clamp

5.7K
Many fundamental cell functions such as muscle contraction and nerve transmission rely on the electrical signals produced by the movement of positively and negatively charged ions across the cell membrane. One competent method to record current flowing across the whole cell or single ion channel is the patch-clamp technique.
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
5.7K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

13.4K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
13.4K
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers01:17

Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers

1.0K
Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
1.0K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

826
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
826

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DNA signatures preserved in the official 1978 sample collection of the Shroud of Turin.

Scientific reports·2026
Same author

Visual arrestin-1: how did we learn what we know today about this protein?

Progress in retinal and eye research·2026
Same author

An isotype-specific phosphorylation of Hsp90 rewires co-chaperone regulations.

The Journal of biological chemistry·2026
Same author

Selective allosteric regulation of Leishmania braziliensis Hsp90 through a parasite-specific regulatory hub.

International journal of biological macromolecules·2026
Same author

Arrestin-3 promotes locomotor sensitization to psychostimulants via JNK signaling in nucleus accumbens.

bioRxiv : the preprint server for biology·2026
Same author

Hijacking client instability to selectively disrupt HSP90-driven glucocorticoid receptor activation.

Pharmacological research·2026

Related Experiment Video

Updated: Sep 12, 2025

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
08:21

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery

Published on: June 28, 2019

7.0K

Arrestins as Possible Drug Targets.

Zeynep Nur Cinviz1, Elisabetta Moroni2, Ozge Sensoy1,3

  • 1Graduate School of Engineering and Natural Sciences, Istanbul Medipol University, Istanbul 34810, Turkey.

Biomolecules & Therapeutics
|August 6, 2025
PubMed
Summary

Arrestins, crucial regulators of cellular signaling, are not currently targeted by drugs. This study explores targeting arrestin interactions for novel therapeutic development, potentially impacting numerous diseases.

Keywords:
ArrestinCell signalingDrug targetGPCR

More Related Videos

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
09:03

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

12.7K
High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
10:07

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels

Published on: January 27, 2013

15.2K

Related Experiment Videos

Last Updated: Sep 12, 2025

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
08:21

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery

Published on: June 28, 2019

7.0K
Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
09:03

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

12.7K
High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
10:07

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels

Published on: January 27, 2013

15.2K

Area of Science:

  • Biochemistry
  • Pharmacology
  • Cellular Biology

Background:

  • G protein-coupled receptors (GPCRs) are a major class of signaling proteins, with fewer than 700 of 20,000 human proteins targeted by drugs.
  • Arrestins are key regulators of GPCRs and other signaling pathways, acting as versatile hubs in cellular signaling.
  • Despite their importance, arrestin proteins are not currently a direct target for any pharmaceutical interventions.

Purpose of the Study:

  • To identify potential drug targets on arrestins and their interacting proteins.
  • To propose strategies for developing compounds that target these interactions.
  • To evaluate the potential research and therapeutic value of modulating arrestin signaling.

Main Methods:

  • Bioinformatic analysis to identify potential arrestin targets.
  • In silico drug design approaches.
  • Literature review of arrestin function and therapeutic potential.

Main Results:

  • Identification of specific arrestin domains and interacting proteins as potential targets.
  • Outlined strategies for small molecule and peptide-based drug development.
  • Hypothesized biological outcomes including modulation of GPCR signaling and cellular trafficking.

Conclusions:

  • Targeting arrestin interactions represents a novel and promising therapeutic strategy.
  • This approach could lead to new treatments for a wide range of diseases.
  • Further research into arrestin-targeted therapies is warranted.